130 related articles for article (PubMed ID: 37244166)
1. A national pharmacovigilance study of haematological adverse drug reactions to clozapine vs other second-generation antipsychotics in Italy.
Bertoli S; Casetta C; Giordano B; D'Agostino A
Schizophr Res; 2023 Jul; 257():25-26. PubMed ID: 37244166
[No Abstract] [Full Text] [Related]
2. Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase.
De Las Cuevas C; Sanz EJ; Rohde C; de Leon J
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):65-78. PubMed ID: 35062840
[TBL] [Abstract][Full Text] [Related]
3. Risk of appendicitis associated with the use of clozapine: A pharmacovigilance study.
Uwai Y; Nabekura T
Asian J Psychiatr; 2022 Nov; 77():103264. PubMed ID: 36150349
[No Abstract] [Full Text] [Related]
4. Data From the World Health Organization's Pharmacovigilance Database Supports the Prominent Role of Pneumonia in Mortality Associated With Clozapine Adverse Drug Reactions.
De Leon J; Sanz EJ; De Las Cuevas C
Schizophr Bull; 2020 Jan; 46(1):1-3. PubMed ID: 31901099
[No Abstract] [Full Text] [Related]
5. An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance.
Sagud M; Breznoscakova D; Celofiga A; Chihai J; Chkonia E; Ristic Ignjatovic D; Injac Stevovic L; Kopecek M; Kurvits K; Kuzo N; Lazáry J; Mazaliauskienė R; Mladina Perisa D; Novotni A; Panov G; Pikirenia U; Rădulescu FȘ; Sukiasyan SG; Taube M; Tomori S; Wilkowska A; De Las Cuevas C; Sanz EJ; de Leon J
Schizophr Res; 2024 Jun; 268():53-59. PubMed ID: 37783650
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
Sayin A; Cosar B
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295
[TBL] [Abstract][Full Text] [Related]
7. Adverse reactions to antipsychotics in Parkinson disease: an analysis of the Spanish pharmacovigilance database.
Lertxundi U; Ruiz AI; Aspiazu MÁ; Domingo-Echaburu S; García M; Aguirre C; García-Moncó JC
Clin Neuropharmacol; 2015; 38(3):69-84. PubMed ID: 25970275
[TBL] [Abstract][Full Text] [Related]
8. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
[TBL] [Abstract][Full Text] [Related]
9. Haematologic malignancies associated with clozapine
Chrétien B; Lelong-Boulouard V; Chantepie S; Sassier M; Bertho M; Brazo P; Humbert X; Alexandre J; Fedrizzi S; Dolladille C
Psychol Med; 2021 Jul; 51(9):1459-1466. PubMed ID: 32036793
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden.
Heinonen E; Forsberg L; Nörby U; Wide K; Källén K
CNS Drugs; 2022 May; 36(5):529-539. PubMed ID: 35220525
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019.
Oh S; Byeon SJ; Chung SJ
J Psychopharmacol; 2022 Sep; 36(9):1041-1050. PubMed ID: 35695641
[TBL] [Abstract][Full Text] [Related]
13. [Intensive pharmacovigilance of clozapine in Argentina].
Balda MV; Daray FM
Vertex; 2015; 26(122):292-301. PubMed ID: 26672506
[TBL] [Abstract][Full Text] [Related]
14. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data.
Beex-Oosterhuis MM; Samb A; Heerdink ER; Souverein PC; Van Gool AR; Meyboom RHB; van Marum RJ
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):725-735. PubMed ID: 32378285
[TBL] [Abstract][Full Text] [Related]
15. Association of First- vs. Second-Generation Antipsychotics with Lipid Abnormalities in Individuals with Severe Mental Illness: A Systematic Review and Meta-Analysis.
Buhagiar K; Jabbar F
Clin Drug Investig; 2019 Mar; 39(3):253-273. PubMed ID: 30675684
[TBL] [Abstract][Full Text] [Related]
16. Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase.
De Las Cuevas C; Sanz EJ; Villasante-Tezanos AG; de Leon J
Expert Opin Drug Metab Toxicol; 2023 Feb; 19(2):57-74. PubMed ID: 36920343
[TBL] [Abstract][Full Text] [Related]
17. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report.
Sacchetti E; Valsecchi P
Int Clin Psychopharmacol; 2003 Nov; 18(6):357-9. PubMed ID: 14571157
[TBL] [Abstract][Full Text] [Related]
19. Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study.
Smith RC; Maayan L; Wu R; Youssef M; Jing Z; Sershen H; Szabo V; Meyers J; Jin H; Zhao J; Davis JM
Psychopharmacology (Berl); 2018 Dec; 235(12):3545-3558. PubMed ID: 30382354
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.
Gianfrancesco FD; Grogg AL; Mahmoud RA; Wang RH; Nasrallah HA
J Clin Psychiatry; 2002 Oct; 63(10):920-30. PubMed ID: 12416602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
